The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF
The amplification of human epidermal growth factor receptor 2 (HER2) gene in breast cancer identifies patients eligible for Trastuzumab therapy. immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) are the only FDA approved techniques for evaluating HER2 status. However, Interobserver variability is still a dilemma
Publish Date
22 - September - 2017
Research Categories
- Scientific
Authors
- سامي أزرق
